The prevention of early-onset neonatal group B streptococcus infection: Technical report from the New Zealand GBS Consensus Working Party

New Zealand Medical Journal

Volumn 117, Issue 1200, 2004, Pages

  Campbell, Norma ^a   Eddy, Alison ^a   Darlow, Brian ^b   Stone, Peter ^c   Grimwood, Keith ^d  

^a New Zealand College of Midwives   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL TRANSMISSION; BRONCHOSPASM; CHILDBIRTH; CONSENSUS DEVELOPMENT; CONTINUING EDUCATION; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; ECONOMIC EVALUATION; FEMALE; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PRACTITIONER; HUMAN; INFECTION RISK; LARYNX SPASM; MEDICAL AUDIT; MEDICAL SOCIETY; MIDWIFE; NEW ZEALAND; NEWBORN; NEWBORN DEATH; NEWBORN INFECTION; NEWBORN MONITORING; NEWBORN MORTALITY; OBSTETRICS; ONSET AGE; PEDIATRICS; PREGNANCY; RELIABILITY; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME; URTICARIA; ANTIBIOTIC PROPHYLAXIS; CONFERENCE PAPER; DISEASE TRANSMISSION; LABOR; PRACTICE GUIDELINE; PREGNANCY COMPLICATION;

ANTIBIOTIC PROPHYLAXIS; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HEALTH POLICY; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; NEW ZEALAND; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 16544386799     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Regan JA, Klebanoff MA, Nugent RP. Vaginal Infections and Prematurity Study Group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol. 1991;77:604-10.
2. Isaacs D, Barfield CP, Grimwood K, et al. Systemic bacterial and fungal infections in infants in Australian neonatal units. Med J Aust. 1995;162:198-201.
3. Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: WB Saunders Co; 2001. p1091-156.
4. Australasian study group for neonatal infections. Early-onset group B streptococcal infections in Aboriginal and non-Aboriginal infants. Med J Aust. 1995; 163:302-6.
5. Schuchat A, Deaver-Robinson K, Plikaytis BD, et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13:623-9.
6. Gilbert GL, Garland SM. Perinatal group B streptococcal infections. Med J Aust. 1983;1:566-71.
7. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis. 1990;162:672-7.
8. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497-513.
9. Stevens JP, Eames M, Kent A, et al. Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F179-84.
10. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665-9.
11. Schuchat A. Group B streptococcus. Lancet. 1999;353:51-6.
12. Smaill F. Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database Syst Rev 2003;1: CD00580.
13. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
14. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child. 2003;88:375-8.
15. Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep 1996;45(RR-7):1-24.
16. Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonisation at delivery. Obstet Gynecol. 1996;88: 811-5.
17. Lynfield R, White K, Danila R, et al. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal care providers - Connecticut and Minnesota, 1998. Morb Mortal Wkly Rep. 2000;49:228-32.
18. Petrova A, Smulian JC, Ananth CV. Obstetrician preferences for prenatal strategies to reduce early-onset group B streptococcal infection in neonates: A population-based survey. Am J Obstet Gynecol. 2002;187:709-14.
19. Factor SH, Whitney CG, Zywicki SS, Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol. 2000;95:377-82.
20. Davies HD, Adair CE, Schuchat A, et al. Physician's prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ. 2001;164:479-85.
21. Isaacs D, Royle JA for the Australasian Study Group for Neonatal Infection. Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia. Pediatr Infect Dis J. 1999;18:524-8.
22. Rouse DJ, Goldenberg RL, Cliver SP, et al. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol. 1994;83:483-94.
23. Gilbert GL, Isaacs D, Burgess MA, et al. Prevention of neonatal group B streptococcal sepsis: Is routine antenatal screening appropriate. Aust N Z Obstet Gynaecol. 1995;35:120-6.
24. Hafner E, Sterniste W, Rosen A, et al. Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol. 1998;179:677-81.
25. Lin FYC, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001;184:1204-10.
26. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233-9.
27. Gilbert GL, Hewitt MC, Turner CM, Leeder SR. Epidemiology and predictive values of risk factors for neonatal group B streptococcal sepsis. Aust N Z J Obstet Gynaecol. 2002;42:497-503.
28. Schrag S, Gorwitz R, Fulz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from the CDC. Morb Mortal Wkly Rep. 2002;51(RR-11)1-22.
29. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol. 1998;92:258-61.
30. Lin F-YC, Azimi PH, Weisman LE, et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis. 2000;31:76-9.
31. Andrews JI, Diekema DJ, Hunter SK, et al. Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol. 2000;183:859-62.
32. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very low-birth-weight infants. N Engl J Med. 2002;347:240-7.
33. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 1998;179:879-83.
34. Schuchat A, Zywicki SS, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000;105:21-6.
35. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3:201-13.
36. Sinha A, Yokoe D, Platt R. Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus. J Pediatr. 2003;142:492-7.
37. Mercer BM, Taylor MC, Fricke JL, et al. The accuracy and patient preference for selfcollected group B streptococcus cultures. Am J Obstet Gynecol 1995;173:1325-8.
38. Oddie S, Embleton ND, on behalf of the Northern Neonatal Network. Risk factors for earlyonset group B streptococcal sepsis: case control study. BMJ. 2002;325:308-12.
39. Stan CM, Boulvain M, Bovier PA, et al. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. Brit J Obstet Gynaecol. 2001;108:840-7.
40. Escobar GJ, Li D-K, Armstrong MA, et al. Neonatal sepsis workups in infants ≥2000 grams at birth: a population-based study. Pediatrics. 2000;106:256-63.
41. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103:e77.
42. Mecredy RL, Wiswell TE, Hume RF. Outcome of term gestation neonates whose mothers received intrapartum antibiotics for suspected chorioamnionitis. Am J Perinatol. 1993;10:365-8.
43. Bromberger P, Lawrence JM, Braun D, et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50.
44. Ottolini MC, Lundgren K, Mirkinson LJ, et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003;22:430-4.
45. De Cueto M, Sanchez M-J, Sampedro A, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91:112-4.
46. Balter S, Zell ER, O'Brien KL, et al. Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J. 2003;22:853-7.
47. Farmer K, Court DJ, Lander JL, et al. A controlled trial of treatment of vaginal carriers of group B streptococci with oral penicillin. Problems in Perinatology: proceedings of the first Asia Oceania Congress of Perinatology. Karim SMM, Tan KL eds. Lancaster, England. MTP Press Ltd, 1980, pp 274-82.
48. Grimwood K, Stone PR, Gosling IA, et al. Late antenatal carriage of group B streptococcus by New Zealand women. Aust N Z J Obstet Gynaecol. 2002;42:182-6.
49. Philipson EH, Palermino DA, Robinson DA. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol. 1995;85:437-9.
50. Stylianopoulis A, Kelly N, Garland S. Is penicillin and/or erythromycin resistance present in clinical isolates of group B streptococcus in our community? Aust N Z J Obstet Gynaecol 2002;42:543-4.
51. Werno AM, Anderson TP, Murdoch DR. Antimicrobial susceptibilities of group B streptococci in New Zealand. Antimicrob Ag Chemother. 2003;47:2710-1.
52. Maxwell FC, Bouchier D. Neonatal septicaemia: a changing picture? N Z Med J. 1991;104:446-7.
53. Grimwood K, Darlow BA, Gosling IA, et al. Early-onset neonatal group B streptococcal infections in New Zealand, 1998-1999. J Paediatr Child Health. 2002;38:272-7.
54. Gosling IA, Stone PR, Grimwood K. Early-onset group B streptococcus prevention protocols in New Zealand public hospitals. Aust N Z J Obstet Gynaecol. 2002;42:362-4.
55. Gosling I, Stone P, Grimwood K. Awareness, knowledge and attitudes of lead maternity carers towards early-onset neonatal group B streptococcal disease. N Z Med J. 2002;115:106-8.
56. Jakobi P, Goldstick O, Sujov P, Istkovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease. Lancet. 2003;361: 351.
57. Gilbert GL. Preventing perinatal group B streptococcal infection: the jury is still out. Med J Aust. 2003;178:199-200.
58. The Royal College of Obstetricians and Gynaecologists (RCOG). Prevention of early onset neonatal group B streptococcal disease; 2003. Available online. URL: http://www.rcog.org.uk Accessed August 2004.
59. National Institute for Clinical Excellence. Antenatal care: routine care for the healthy pregnant woman; 2003. Available online. URL: http://www.nice.org.uk Accessed August 2004.
60. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Swabbing for group B streptococcus; 2003. Available online. URL: http://www.ranzcog.edu.au Accessed August 2004.
61. Haberland CA, Benitz WE, Sanders GD, et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics. 2002;110:471-80.
62. Hansen SM, Uldbjerg N, Kilian M, Skove Sorenesen UB. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol. 2004;42:83-9.
63. Sneyd E, Baker M. Infectious diseases in New Zealand: 2002 annual surveillance summary. Wellington: ESR/MOH; 2003. Available online. URL: http://www.surv.esr.cri.nz/surveillance/surveillance.php Accessed August 2004.
64. Weisman LE, Stoll BJ, Cruess DF, et al. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr. 1992;121: 428-33.